With 0.28 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.31 million shares. During the session, the Medical Devices company that operates in wider Healthcare sector, reached to the highest price of $0.7772 whereas the lowest price it dropped to was $0.7. The 52-week range on NMTC shows that it touched its highest point at $1.39 and its lowest point at $0.40 during that stretch. It currently has a 1-year price target of $3.00. Beta for the stock currently stands at 0.57.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of NMTC was up-trending over the past week, with a rise of 14.64%, but this was up by 15.30% over a month. Three-month performance dropped to -14.82% while six-month performance rose 4.90%. The stock lost -7.28% in the past year, while it has gained 1.00% so far this year. A look at the trailing 12-month EPS for NMTC yields -0.08 with Next year EPS estimates of -0.14. For the next quarter, that number is -0.04. This implies an EPS growth rate of -88.89% for this year and 17.65% for next year.
Float and Shares Shorts:
At present, 50.01 million NMTC shares are outstanding with a float of 46.72 million shares on hand for trading. On 2025-12-15, short shares totaled 0.11 million, which was 21.0 higher than short shares on 1763078400. In addition to Mr. David A. Rosa M.D. as the firm’s President, CEO & Director, Mr. Ronald W. McClurg serves as its Chief Financial Officer.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2025-09-30, NMTC reported revenue of $2740925.0 and operating income of -$1371064.0. The EBITDA in the recently reported quarter was -$1240146.0 and diluted EPS was $nan.
Analysts Ratings:
In the same way, a target price assigned to a stock can also reveal much about its potential. With NMTC analysts setting a high price target of 3.0 and a low target of 1.45, the average target price over the next 12 months is 2.225. Based on these targets, NMTC could surge 289.61% to reach the target high and rise by 88.31% to reach the target low. Reaching the average price target will result in a growth of 188.96% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.35362 being high and -$0.46638 being low. For NMTC, this leads to a yearly average estimate of -$0.41.
